NeuroSense Therapeutics (NRSN) Q3 2025 Earnings

1AugConfirmed
Q4 2024
Q2 2025
Q2 2025
Q3 2025
-0.22
-0.16
-0.1
-0.04

Details

Expected EPS
-0.2226
Actual EPS
-0.1377
Surprise EPS
0.08
Surprise Percent
+38.14%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.1377 per share for Q3 2025.

0 Comments

Share your thoughts